French registry of severe acute kidney injury in hospital
Part of Heart & circulation, Kidney & urinary, Women’s health & pregnancy clinical trials.
Acute Kidney Injury (AKI) is a common and serious condition in hospitalized patients, especially when it reaches stages 2 or 3 according to the KDIGO classification. These severe forms are associated with high mortality, a risk of progression to chronic kidney disease (CKD), and frequent cardiovascular complications. However, current data on how nephrologists manage these patients during hospitalization-and how these practices influence long-term outcomes-are limited and heterogeneous. The FAKIR study (French AKI Registry) is a prospective, multicenter, non-interventional observational study designed to describe the clinical management of patients admitted to nephrology departments for AKI stage 2 or 3 and to assess their renal and cardiovascular outcomes up to one year. The study hypothesizes that better characterization of in-hospital practices and patient trajectories will help identify predictors of renal recovery, progression to end-stage renal disease, and major cardiovascular events. Patients will be followed during hospitalization and at 3, 6, and 12 months to assess renal function, mortality, cardiovascular events, and rehospitalizations. This registry aims to provide real-life, multicenter data to support future guidelines and the development of structured post-AKI care pathways.
Summary from the official registry record.
Who can take part
- You must be 18 years or older.
- You must be admitted to a hospital kidney (nephrology) ward or intensive kidney care unit.
- You must have a diagnosis of acute kidney injury (sudden kidney damage) that is stage 2 or 3 (moderate to severe).
- Your medical team must be able to follow up with you 3 months after discharge to check your recovery.
- You must agree to allow your medical information to be used for research.
- You cannot have only mild kidney injury (stage 1) or be hospitalized for another reason without a stage 2 or 3 kidney injury.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at acute kidney injury in patients who are very sick in the intensive care unit (ICU). It may help doctors better understand and manage kidney problems in these patients.
This study follows hospitalized adults with or without acute kidney injury to learn more about the condition. You may join if you are 18 or older and can give consent.
This trial tests ways to protect the kidneys in intensive-care patients who have moderate or severe acute kidney injury. If you are on a ventilator or medications to support blood pressure, this study may offer extra kidney care to help prevent further damage.
This study looks back at adults who visited certain hospitals in South Korea to understand what leads to acute kidney injury (a sudden drop in kidney function) and how it affects recovery. It compares people who had this condition with similar people who did not, to identify risk factors.
This study helps improve care for people with moderate to severe acute kidney injury when they leave the hospital. It tests a program to make sure patients get the right follow-up once they go home.
This study helps doctors better assess how well kidneys recover after acute kidney injury (a sudden loss of kidney function during hospitalization). You may be asked to participate in interviews, workshops, or have some medical measurements taken to help improve patient care.
Hear when a new Acute Kidney Injury trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.